BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22503811)

  • 1. Clusters within a wide spectrum of biochemical markers for osteoarthritis: data from CHECK, a large cohort of individuals with very early symptomatic osteoarthritis.
    van Spil WE; Jansen NW; Bijlsma JW; Reijman M; DeGroot J; Welsing PM; Lafeber FP
    Osteoarthritis Cartilage; 2012 Jul; 20(7):745-54. PubMed ID: 22503811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-sectional and predictive associations between plasma adipokines and radiographic signs of early-stage knee osteoarthritis: data from CHECK.
    Van Spil WE; Welsing PM; Kloppenburg M; Bierma-Zeinstra SM; Bijlsma JW; Mastbergen SC; Lafeber FP
    Osteoarthritis Cartilage; 2012 Nov; 20(11):1278-85. PubMed ID: 22890184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ability of systemic biochemical markers to reflect presence, incidence, and progression of early-stage radiographic knee and hip osteoarthritis: data from CHECK.
    Van Spil WE; Welsing PM; Bierma-Zeinstra SM; Bijlsma JW; Roorda LD; Cats HA; Lafeber FP
    Osteoarthritis Cartilage; 2015 Aug; 23(8):1388-97. PubMed ID: 25819579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic biochemical markers of joint metabolism and inflammation in relation to radiographic parameters and pain of the knee: data from CHECK, a cohort of early-osteoarthritis subjects.
    Van Spil WE; Nair SC; Kinds MB; Emans PJ; Hilberdink WK; Welsing PM; Lafeber FP
    Osteoarthritis Cartilage; 2015 Jan; 23(1):48-56. PubMed ID: 25205017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of markers of matrix metabolism, inflammation markers, and adipokines with superior cam deformity of the hip and their relation with future hip osteoarthritis.
    van Spil WE; Agricola R; Drossaers-Bakker KW; Weinans H; Lafeber FP
    Osteoarthritis Cartilage; 2015 Nov; 23(11):1897-905. PubMed ID: 26521735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of CTX-II with biochemical markers of bone turnover raise questions on its tissue origin: data from CHECK, a cohort study of early osteoarthritis.
    van Spil WE; Drossaers-Bakker KW; Lafeber FP
    Ann Rheum Dis; 2013 Jan; 72(1):29-36. PubMed ID: 22689318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-sectional association of 10 molecular markers of bone, cartilage, and synovium with disease activity and radiological joint damage in patients with hip osteoarthritis: the ECHODIAH cohort.
    Garnero P; Mazières B; Guéguen A; Abbal M; Berdah L; Lequesne M; Nguyen M; Salles JP; Vignon E; Dougados M
    J Rheumatol; 2005 Apr; 32(4):697-703. PubMed ID: 15801028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between biomarkers of matrix metabolism and inflammation with pain and fatigue in participants suspected of early hip and or knee osteoarthritis: data from the CHECK study.
    van Berkel AC; van Spil WE; Schiphof D; Runhaar J; van Ochten JM; Bindels PJE; Bierma-Zeinstra SMA
    Osteoarthritis Cartilage; 2022 Dec; 30(12):1640-1646. PubMed ID: 36115527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between biomarkers of cartilage, bone, synovial metabolism and knee pain provide insights into the origins of pain in early knee osteoarthritis.
    Ishijima M; Watari T; Naito K; Kaneko H; Futami I; Yoshimura-Ishida K; Tomonaga A; Yamaguchi H; Yamamoto T; Nagaoka I; Kurosawa H; Poole RA; Kaneko K
    Arthritis Res Ther; 2011 Feb; 13(1):R22. PubMed ID: 21320321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between biomarkers of bone and cartilage turnover, gender, pain categories and radiographic severity in knee osteoarthritis.
    Bihlet AR; Byrjalsen I; Bay-Jensen AC; Andersen JR; Christiansen C; Riis BJ; Karsdal MA
    Arthritis Res Ther; 2019 Sep; 21(1):203. PubMed ID: 31481084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between ultrasonographic findings and bone/cartilage biomarkers in patients with early-stage knee osteoarthritis.
    Kumm J; Tamm A; Lintrop M; Tamm A
    Calcif Tissue Int; 2009 Dec; 85(6):514-22. PubMed ID: 19862466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a 16 weeks weight loss program on osteoarthritis biomarkers in obese patients with knee osteoarthritis: a prospective cohort study.
    Bartels EM; Christensen R; Christensen P; Henriksen M; Bennett A; Gudbergsen H; Boesen M; Bliddal H
    Osteoarthritis Cartilage; 2014 Nov; 22(11):1817-25. PubMed ID: 25106676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum and urinary biochemical markers for knee and hip-osteoarthritis: a systematic review applying the consensus BIPED criteria.
    van Spil WE; DeGroot J; Lems WF; Oostveen JC; Lafeber FP
    Osteoarthritis Cartilage; 2010 May; 18(5):605-12. PubMed ID: 20175979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large scale meta-analysis of urinary C-terminal telopeptide, serum cartilage oligomeric protein and matrix metalloprotease degraded type II collagen and their role in prevalence, incidence and progression of osteoarthritis.
    Valdes AM; Meulenbelt I; Chassaing E; Arden NK; Bierma-Zeinstra S; Hart D; Hofman A; Karsdal M; Kloppenburg M; Kroon HM; Slagboom EP; Spector TD; Uitterlinden AG; van Meurs JB; Bay-Jensen AC
    Osteoarthritis Cartilage; 2014 May; 22(5):683-9. PubMed ID: 24576742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis identifies loci affecting levels of the potential osteoarthritis biomarkers sCOMP and uCTX-II with genome wide significance.
    Ramos YF; Metrustry S; Arden N; Bay-Jensen AC; Beekman M; de Craen AJ; Cupples LA; Esko T; Evangelou E; Felson DT; Hart DJ; Ioannidis JP; Karsdal M; Kloppenburg M; Lafeber F; Metspalu A; Panoutsopoulou K; Slagboom PE; Spector TD; van Spil EW; Uitterlinden AG; Zhu Y; ; ; Valdes AM; van Meurs JB; Meulenbelt I
    J Med Genet; 2014 Sep; 51(9):596-604. PubMed ID: 25057126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between biochemical cartilage markers and clinical symptoms in patients with hip osteoarthritis: cohort study with 2-year follow-up.
    Dorleijn DM; Luijsterburg PA; Bay-Jensen AC; Siebuhr AS; Karsdal MA; Rozendaal RM; Bos PK; Bierma-Zeinstra SM
    Osteoarthritis Cartilage; 2015 Jan; 23(1):57-62. PubMed ID: 25205018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of urinary CTX-II and NTX-I in evaluating radiological knee osteoarthritis : the Matsudai knee osteoarthritis survey.
    Tanishi N; Yamagiwa H; Hayami T; Mera H; Koga Y; Omori G; Endo N
    J Orthop Sci; 2014 May; 19(3):429-36. PubMed ID: 24504986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers for osteoarthritis: Can they be used for risk assessment? A systematic review.
    Hosnijeh FS; Runhaar J; van Meurs JB; Bierma-Zeinstra SM
    Maturitas; 2015 Sep; 82(1):36-49. PubMed ID: 25963100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal relationship between serum adipokines, biomarkers of bone and cartilage turnover, and cartilage volume loss in a population with clinical knee osteoarthritis.
    Berry PA; Jones SW; Cicuttini FM; Wluka AE; Maciewicz RA
    Arthritis Rheum; 2011 Mar; 63(3):700-7. PubMed ID: 21305502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular markers of cartilage breakdown and synovitis at baseline as predictors of structural progression of hip osteoarthritis. The ECHODIAH Cohort.
    Mazières B; Garnero P; Guéguen A; Abbal M; Berdah L; Lequesne M; Nguyen M; Salles JP; Vignon E; Dougados M
    Ann Rheum Dis; 2006 Mar; 65(3):354-9. PubMed ID: 16322084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.